Variant report
Variant | nsv466311 |
---|---|
Chromosome Location | chr9:25263918-25352327 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:9)
- LncRNA region (count:2)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:9 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr9:25350133..25352434-chr9:25677647..25679713,3 | MCF-7 | breast: | |
2 | chr9:25349920..25350511-chr9:25716130..25716944,2 | MCF-7 | breast: | |
3 | chr9:25346387..25349185-chr9:25351167..25353046,2 | MCF-7 | breast: | |
4 | chr9:25321931..25322446-chr9:25349957..25350559,2 | MCF-7 | breast: | |
5 | chr9:24613953..24614528-chr9:25350122..25350850,2 | MCF-7 | breast: | |
6 | chr9:25346387..25349185-chr9:25351167..25353046,2 | MCF-7 | breast: | |
7 | chr9:25267661..25270080-chr9:25677540..25679201,2 | MCF-7 | breast: | |
8 | chr9:25321931..25322446-chr9:25349957..25350559,2 | MCF-7 | breast: | |
9 | chr9:25292451..25293431-chr9:25673511..25674229,2 | MCF-7 | breast: |
(count:2 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-TUSC1-1 | chr9:25290336-25290489 | NONHSAT130499 |
2 | lnc-TUSC1-1 | chr9:25288488-25288555 | NONHSAT130499 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000198680 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs1758734 | chr9:25263918-25263919 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs569402491 | chr9:25263924-25263925 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs369634245 | chr9:25263944-25263945 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs551742712 | chr9:25263946-25263947 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs531864072 | chr9:25263948-25263949 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs551863568 | chr9:25263955-25263956 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs148917370 | chr9:25263964-25263965 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs375863857 | chr9:25263995-25263996 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs533939070 | chr9:25264078-25264079 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs554078083 | chr9:25264095-25264096 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs560852923 | chr9:25264107-25264108 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs145643973 | chr9:25264116-25264117 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs536475822 | chr9:25264127-25264128 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs76980982 | chr9:25264147-25264148 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs575800945 | chr9:25264199-25264200 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs117341558 | chr9:25264258-25264259 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs71508633 | chr9:25264264-25264265 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs572052011 | chr9:25264311-25264312 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs190483896 | chr9:25264312-25264313 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs560873488 | chr9:25264327-25264328 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs183418589 | chr9:25264339-25264340 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs187131611 | chr9:25264353-25264354 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs563088445 | chr9:25264358-25264359 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs58041934 | chr9:25264393-25264394 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs551907120 | chr9:25264408-25264409 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs565224905 | chr9:25264455-25264456 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs527718991 | chr9:25264519-25264520 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs57765859 | chr9:25264525-25264526 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs191913088 | chr9:25264539-25264540 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs184154833 | chr9:25264540-25264541 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs569520762 | chr9:25264542-25264543 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs141450997 | chr9:25264599-25264600 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs558268931 | chr9:25264602-25264603 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs994896 | chr9:25264689-25264690 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs534639526 | chr9:25264721-25264722 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs74399764 | chr9:25264724-25264725 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs186554477 | chr9:25264728-25264729 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs543353223 | chr9:25264747-25264748 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs10966821 | chr9:25264749-25264750 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs1758735 | chr9:25264753-25264754 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs545603223 | chr9:25264820-25264821 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs565407360 | chr9:25264838-25264839 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs79667893 | chr9:25264849-25264850 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs547837416 | chr9:25264854-25264855 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs370747513 | chr9:25264855-25264856 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs529993684 | chr9:25264872-25264873 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs549714295 | chr9:25264896-25264897 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs569602980 | chr9:25264916-25264917 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs145178081 | chr9:25264917-25264918 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs552062914 | chr9:25264923-25264924 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Lung cancer | 18438408 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Developmental delay | 21147756 | CNVD |
Pilocytic astrocytoma | 18670637 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Melanoma | 22183965 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Cancer | 22183965 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Glioblastoma multiforme | 19435819 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Glioblastoma multiforme | 22291905 | CNVD |
Lung cancer | 21911935 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
head and neck squamous cell carcinoma | 21798897 | CNVD |
Cancer | 21253487 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Intracranial ependymoma | 16609018 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Glioma | 17123091 | CNVD |
Mental retardation | 17124404 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
Acute lymphoblastic leukemia | 18768390 | CNVD |
Leukemia | 19602459 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Leukemia | 18688285 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Acute myeloid leukemia | 19651601 | CNVD |
Coronary Disease | 20032323 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Cancer | 21732550 | CNVD |
Gastric cancer | 22539939 | CNVD |
Cancer | 21183584 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Metastatic melanoma | 18483359 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Cervical cancer | 21062161 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Glioblastoma | 17090523 | CNVD |
Lung cancer | 16773561 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Bladder cancer | 19088036 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Melanoma | 16977458 | CNVD |
Glioblastoma multiforme | 17369134 | CNVD |
Chagasic megaesophagus | 20163722 | CNVD |
Melanoma | 19566914 | CNVD |
Squamous cell cancer | 19047905 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Hodgkin''s lymphoma | 18179710 | CNVD |
Adenoid cystic carcinoma | 18332873 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Oral cancer | 21386901 | CNVD |
Breast cancer | 21858162 | CNVD |
Breast cancer | 21364760 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Lung cancer | 21569311 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Chordoma | 21215367 | CNVD |
Bipolar disorder | 19114987 | CNVD |
Non-small cell lung cancer | 16651412 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:25260200-25265000 | Weak transcription | Fetal Kidney | kidney |
2 | chr9:25265000-25268000 | Active TSS | Fetal Kidney | kidney |
3 | chr9:25266800-25267200 | ZNF genes & repeats | ES-UCSF4 Cell Line | embryonic stem cell |
4 | chr9:25283600-25283800 | Enhancers | Fetal Lung | lung |
5 | chr9:25283800-25284600 | Weak transcription | Fetal Lung | lung |
6 | chr9:25284600-25285400 | Enhancers | Fetal Lung | lung |
7 | chr9:25286600-25288200 | ZNF genes & repeats | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
8 | chr9:25287800-25288200 | Enhancers | HUES6 Cell Line | embryonic stem cell |
9 | chr9:25288000-25288200 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
10 | chr9:25289200-25291200 | ZNF genes & repeats | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
11 | chr9:25291800-25292000 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
12 | chr9:25292000-25292400 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
13 | chr9:25292400-25295600 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
14 | chr9:25295400-25296200 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
15 | chr9:25295600-25296000 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
16 | chr9:25295600-25296000 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
17 | chr9:25310800-25312000 | Enhancers | Fetal Brain Male | brain |
18 | chr9:25311000-25311400 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
19 | chr9:25311000-25311400 | Enhancers | Adipose Nuclei | Adipose |
20 | chr9:25323400-25323800 | Enhancers | HUES48 Cell Line | embryonic stem cell |
21 | chr9:25323800-25325400 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
22 | chr9:25325400-25325600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
23 | chr9:25325600-25326000 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
24 | chr9:25325800-25326200 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
25 | chr9:25325800-25326200 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
26 | chr9:25326000-25326400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
27 | chr9:25334400-25334600 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
28 | chr9:25347200-25348400 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
29 | chr9:25350000-25350200 | Enhancers | Fetal Brain Male | brain |